CoChat

Amyloid and tau proteins in cortical brain biopsy and Alzheimer's disease

Leinonen, Ville, Koivisto, Anne M., Savolainen, Sakari, Rummukainen, Jaana, Tamminen, Juuso N., Tillgren, Tomi, Vainikka, Sannakaisa, Pyykkö, Okko T., Mölsä, Juhani, Fraunberg, Mikael, Pirttilä, Tuula, Jääskeläinen, Juha E., Soininen, Hilkka, Rinne, Jaakko, Alafuzoff, Irina · 2010 · Annals of Neurology
Cited by 150

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

Objective: Amyloid‐β(Aβ) aggregates are presumed to be found in the brain at an early stage of Alzheimer's disease (AD) but have seldom been assessed by brain biopsy during life in often elderly patients. Methods: Between 1991 and 2006 we evaluated 468 patients with suspected normal pressure hydrocephalus with intraventricular pressure monitoring and a right frontal cortical biopsy sample immunostained for Aβ and hyperphosphorylated tau (HPτ). Adequate samples and the clinical follow‐up data until death or the end of 2008, available in 433 cases, were reviewed for the clinical signs of dementia, including AD. Logistic regression analysis was used to analyze whether Aβ and/or HPτ in the biopsy samples obtained during life predicted development of cognitive impairment, in particular, AD. Results: Of the 433 frontal cortical samples, 42 (10%) displayed both Aβ and HPτ, 144 (33%) Aβ only, and 247 (57%) neither Aβ nor HPτ. In a median follow‐up time of 4.4 years, 94 patients (22%) developed clinical AD. The presence of both Aβ and HPτ was strongly associated (odds ratio [OR], 68.2; 95% confidence interval [CI], 22.1–210) and Aβ alone significantly associated (OR, 10.8; 95% CI, 4.9–23.8) with the clinical diagnosis of AD. Interpretation: This is the largest follow‐up study of patients assessed for the presence of Aβ and HPτ in frontal cortical brain biopsy samples. 1) The presence of Aβ and HPτ spoke strongly for the presence or later development of clinical AD; 2) Aβ alone was suggestive of AD; and 3) the absence of Aβ and HPτ spoke against a later clinical diagnosis of AD. Ann Neurol 2010;68:446–453

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.22100

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

See all 150

Metadata

Authors
Leinonen, V., Koivisto, A. M., Savolainen, S., Rummukainen, J., Tamminen, J. N., Tillgren, T., Vainikka, S., Pyykkö, O. T., Mölsä, J., Fraunberg, M., Pirttilä, T., Jääskeläinen, J. E., Soininen, H., Rinne, J., & Alafuzoff, I.
Venue
Annals of Neurology
Publisher
Wiley
Published
2010-10
Volume
68
Issue
4
Pages
446-453
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W2097870720
Cited by
150
References
15
FWCI
6.28
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Amyloid and tau proteins in cortical brain biopsy and Alzheimer's disease. https://app.cochat.ai/papers/10.1002/ana.22100
The paper
Leinonen, V., Koivisto, A. M., Savolainen, S., Rummukainen, J., Tamminen, J. N., Tillgren, T., Vainikka, S., Pyykkö, O. T., Mölsä, J., Fraunberg, M., Pirttilä, T., Jääskeläinen, J. E., Soininen, H., Rinne, J., & Alafuzoff, I. (2010). Amyloid and tau proteins in cortical brain biopsy and Alzheimer's disease. Annals of Neurology. https://doi.org/10.1002/ana.22100

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.